Screener
Indivior Pharmaceuticals, Inc. INDV Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses | 15 | 34 |
| Current tax receivable | 12 | 2 |
| Other current assets | 40 | 16 |
| Total current assets | 667 | 652 |
| Long-term investments | 27 | 28 |
| Property, plant and equipment, net | 157 | 144 |
| Operating lease right of use assets, net | 22 | 26 |
| Goodwill and other intangible assets, net | 2 | 2 |
Item 1. Unaudited Condensed Financial Statements.
FAQ
- What is Indivior Pharmaceuticals, Inc.'s total current assets?
- Indivior Pharmaceuticals, Inc. (INDV) reported total current assets of $667M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s total current assets decreased by 24.5% year-over-year, from $883M to $667M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s total current assets?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc.'s total current assets has grown at a -28.0% compound annual growth rate (CAGR), from $1.26B to $652M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Indivior Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude